This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Broad spectrum antibiotics chloramphenicol, anaerobic,soil bacteria. Description includes Physicochemical Properties,Mechanism of action-50S ribosome ,Inhibits Bacterial protein synthesis,Resistance,Interactions,Indications of chloramphenicol-Pyogenic meningitis.
Anaerobic infections.
Intraocular infections.
Enteric fever
Drug of choice in some conditions.
Urinary tract infections
Topically In conjunctivitis & external ear Infections. Snehal chakorkar
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Broad spectrum antibiotics chloramphenicol, anaerobic,soil bacteria. Description includes Physicochemical Properties,Mechanism of action-50S ribosome ,Inhibits Bacterial protein synthesis,Resistance,Interactions,Indications of chloramphenicol-Pyogenic meningitis.
Anaerobic infections.
Intraocular infections.
Enteric fever
Drug of choice in some conditions.
Urinary tract infections
Topically In conjunctivitis & external ear Infections. Snehal chakorkar
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
Sulfonamide (also called sulphonamide, sulfa drugs or sulpha drugs) is the basis of several groups of drugs. The original antibacterial sulfonamides are synthetic antimicrobial agents that contain the sulfonamide group.
These are antibiotics having a macrocyclic
lactone ring with attached sugars. Erythromycin
is the first member discovered in the 1950s,
Roxithromycin, Clarithromycin and Azithromycin
are the later additions. Antimicrobial spectrum is narrow,
includes mostly gram-positive and a few gramnegative
bacteria, and overlaps considerably with
that of penicillin G. Erythromycin is highly active
against Str. pyogenes and Str. pneumoniae, N.
gonorrhoeae, Clostridia, C. diphtheriae and
Listeria, but penicillin-resistant Staphylococci
and Streptococci are now resistant to erythromycin
also.
All cocci readily develop resistance
to erythromycin, mostly by acquiring the
capacity to pump it out. Resistant Enterobacteriaceae
have been found to produce an erythromycin
esterase. Alteration in the ribosomal binding
site for erythromycin by a plasmid encoded
methylase enzyme is an important mechanism of
resistance in gram-positive bacteria. All the above
types of resistance are plasmid mediated. Change
in the 50S ribosome by chromosomal mutation
reducing macrolide binding a
synthetic antimicrobials having a quinolone structure that are active primarily against gram-negative bacteria, though newer fluorinated compounds also inhibit gram-positive ones.
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
Sulfonamide (also called sulphonamide, sulfa drugs or sulpha drugs) is the basis of several groups of drugs. The original antibacterial sulfonamides are synthetic antimicrobial agents that contain the sulfonamide group.
These are antibiotics having a macrocyclic
lactone ring with attached sugars. Erythromycin
is the first member discovered in the 1950s,
Roxithromycin, Clarithromycin and Azithromycin
are the later additions. Antimicrobial spectrum is narrow,
includes mostly gram-positive and a few gramnegative
bacteria, and overlaps considerably with
that of penicillin G. Erythromycin is highly active
against Str. pyogenes and Str. pneumoniae, N.
gonorrhoeae, Clostridia, C. diphtheriae and
Listeria, but penicillin-resistant Staphylococci
and Streptococci are now resistant to erythromycin
also.
All cocci readily develop resistance
to erythromycin, mostly by acquiring the
capacity to pump it out. Resistant Enterobacteriaceae
have been found to produce an erythromycin
esterase. Alteration in the ribosomal binding
site for erythromycin by a plasmid encoded
methylase enzyme is an important mechanism of
resistance in gram-positive bacteria. All the above
types of resistance are plasmid mediated. Change
in the 50S ribosome by chromosomal mutation
reducing macrolide binding a
synthetic antimicrobials having a quinolone structure that are active primarily against gram-negative bacteria, though newer fluorinated compounds also inhibit gram-positive ones.
Chloramphenicol Pharmacology-
Topics covered:-
1. Introduction
2. Structure
3. Mechanism Of Action
4. Bacterial Resistance to Chloramphenicol
5. Antimicrobial Spectrum
6. Pharmacokinetics
7. Adverse Effects
8. Drug Interactions
9. Therapeutic Uses
Chloramphenicol, a potent and versatile antibiotic, has played a significant role in the field of medicine since its discovery in the late 1940s. This broad-spectrum antibiotic is highly effective against a wide range of bacteria, making it a valuable tool in the fight against infectious diseases. However, its history is marked by controversies and challenges, which have influenced its usage and regulation.
Chloramphenicol was first isolated from the bacterium Streptomyces venezuelae in 1947, marking a significant milestone in the development of antibiotics. Its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit distinguishes it as a bacteriostatic agent. This mode of action makes chloramphenicol effective against various Gram-positive and Gram-negative bacteria, including some drug-resistant strains.
Despite its efficacy, chloramphenicol's history is marred by concerns about its safety. In the 1950s and 1960s, it was widely used as a broad-spectrum antibiotic for various infections. However, it was later associated with a potentially life-threatening condition known as "gray baby syndrome" in neonates, leading to restrictions on its use in children and pregnant women. Additionally, it has been linked to aplastic anemia, a rare but serious side effect, which led to further restrictions on its use in many countries.
The complex history of chloramphenicol extends to its current status in the medical field. While it is still used in some cases, it is typically reserved for situations where other antibiotics have failed, and safer alternatives are unavailable. The availability and regulation of chloramphenicol vary from country to country due to these concerns.
In recent years, research has focused on understanding the molecular mechanisms of chloramphenicol's action and the development of more targeted antibiotics with improved safety profiles. Its unique characteristics and historical significance continue to make it a subject of interest in the ongoing battle against bacterial infections.
In conclusion, chloramphenicol is a potent broad-spectrum antibiotic with a rich and complex history. Its discovery revolutionized the treatment of infectious diseases, but safety concerns have led to restricted use. Ongoing research seeks to balance its efficacy with safety, highlighting the ongoing importance of this antibiotic in the field of medicine.
At the end of this e-learning session you are able to…
A. Discuss Mechanism of action of chloramphenicol
B. Give classification and Explain pharmacology of chloramphenicol.
For 30+ video lecture series on Pharmacology Experiment as per PCI B Pharm Syllabus refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1Ba6WSJjeBaK0HMF79hdad3g
For 2+ video lecture series on Pharmacoeconomics refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BY8U1TnlcHttsRB8hwpoJRL
For 5+ video lecture series on Pharmacoepidemiology refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BbqIaLoMmuF0Bf66SMFZtnb
For 5+ video lecture series on Drug discovery refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1Bbn9IE6c4MagVHZMNNinJov
For 5+ video lecture series on Drugs used in Special population use link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BZAed7zkXxyrgomJx2sSwHR
For 5+ video lecture series on Adverse Drug Reaction use link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BbWpd06N6RcV2q0K3JT29Wv
For 2+ video lecture series on Therapeutic drug monitoring refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BZQtOerZuDjx4yo0eOeTHIy
For 26+ video lecture series on Drugs act on central nervous system refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BY9xHaplYCYG26ALtIQp5aC
For 6+ video lecture series on drugs act on Gastrointestinal tract refer link given below: https://www.youtube.com/playlist?list=PLBVbJ9HCa1BYgHRHwuarKTt96bu_2L5WK
To support this channel you can through UPI ID: abushaikh07-yahoo.com@okhdfcbank
For More Such Learning You Can Subscribe to My YouTube Channel: https://www.youtube.com/channel/UC5o-WkzmDJaF7udyAP2jtgw/featured?sub_confirmation=1
Facebook Page: https://www.facebook.com/asacademylearningforever
Website Blog: https://itasacademy.blogspot.com/
Hello friends. In this PPT I am talking about antiepileptic drugs. If you like it, please do let me know in the comments section. A single word of appreciation from you will encourage me to make more of such videos. Thanks. Enjoy and welcome to the beautiful world of pharmacology where pharmacology comes to life. This video is intended for MBBS, BDS, paramedical and any person who wishes to have a basic understanding of the subject in the simplest way.
antidotes and their MOA
An antidote is a substance which can counteract a form of poisoning. The term ultimately derives from the Greek αντιδιδοναι antididonai, "given against"
3. prophylactic use of Anti-microbial agentsJagirPatel3
Prophylactic: A preventive measure. The word comes from the Greek for "an advance guard," an apt term for a measure taken to fend off a disease or another unwanted consequence
1. chemotherapy principles and problems JagirPatel3
The objective of chemotherapy is to study and to apply the drugs that have highly selective toxicity to the pathogenic microorganisms in the host body and have no or less toxicity to the host, so as to prevent and cure infective diseases caused by pathogens
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. • Chloramphenicol was initially obtained from Streptomyces Venezuela
• It was soon synthesized chemically and the commercial product now is all
synthetic
• It has a nitrobenzene substitution, which is probably responsible for the
antibacterial activity and its intensely bitter taste.
3. • Chloramphenicol is primarily bacteriostatic, though high concentrations Have
been shown to exert cidal effect on some bacteria.
• Chloramphenicol was highly active against Salmonella including S. typhi, but
resistant strains are now rampant.
• It is more active than tetracyclines against H. influenzne (though many have
now developed resistance), B. pertussis, Klebsiella, N.meningitidis and
anaerobes including Bact. fragilis.
• It is less active against gram-positive cocci, spirochetes, certain
Enterobacteriaceae and Chlamydia. Entamoeba and Plasmodia are not inhibited.
6. • Resistance to chloramphenicol is caused by
Resistance
Ribosomal
mutation
Decreased permeability of drug to
microbial cell wall
Production of inactivating enzyme,
acetlytransferase, e.g. H.influenza, S.typhi S.aureus
7. • Duration: Typhoid: 8-10 days; meningitis: 7-10 days; brain abscess: Up to 4 wk.
• Absorption: Readily absorbed with peak plasma concentrations after 1 or 2 hr
(oral).
• Distribution: Distributed widely into tissues and fluids, CSF, eye, crosses the
placenta and enters the breast milk. Protein-binding: 60%.
• Metabolism: Hydrolysed to the free drug in the GI tract (palmitate); liver by
conjugation with glucuronic acid, lungs and kidneys after parenteral admin
(sodium succinate).
• Excretion: Via the urine, via the bile (3%), via the faeces (1% as inactive form);
1.5-4 hr (elimination half-life).
8. • Hypersensitive reactions: sin rashes, fever, and angioedema
• GIT: nausea, vomiting, diarrhoea
• Anemias: Patients may experience dose-related anemia, hemolytic anemia (seen in patients
with glucose-6-phosphate dehydrogenase deficiency), and aplastic anemia. [Note: Aplastic
anemia is independent of dose and may occur after therapy has ceased.]
• Bone marrow suppression:
• The most serious ADV of chloramphenicol, is on bone marrow, it occurs in two ways
Dose dependent reversible suppression, which manifests
anemia, leukopenia, and thrombocytopenia.
Non dose related: which is fatal
9. • Gray baby syndrome (also termed Gray or Grey syndrome) is a rare but
serious side effect that occurs in newborn infants
• Pathophysiology
• Due to lack of The UDP- glucuronyl transferase enzyme system of infants,
especially premature infants, is immature and incapable of metabolizing the
excessive drug load.
• Insufficient renal excretion of the unconjugated drug.
10. • Loss of appetite
• Vomiting
• Ashen gray color of the skin
• Hypotension (low blood pressure)
• Cyanosis (blue discolouration of lips and skin)
• Hypothermia
• Cardiovascular collapse
• Abdominal distension
• Irregular respiration
• Increased blood lactate
11. 1. Paracetamol + chloramphenicol = enhances bioavailability of
chloramphenicol by 28 %
2. Chloramphenicol is potent enzyme inhibitor and inhibits metabolism of
3. warfarin = increase risk of bleeding
4. Morphine = respiratory depression
5. Chorpropamide = increase hypoglycaemia
6. Chloramphenicol + Penicillins can cause antibiotic antagonism.
12. • Anaerobic infections: B.fragilis, in combination with metronidazole for treatment of
brain, lungs, intra abdominal, or pelvic abscess
• Eye and ear infections
• Brucellosis
• Because of its toxic side effects, chloramphenicol is used only to suppress
infections that cannot be treated effectively with other antibiotics. Such
infections typically include
• (1) Typhoid fever
• (2) Meningococcal infections in cephalosporin-allergic patients
• (3) Serious H. influenzae infections, particularly in cephalosporin-allergic patients
• (4) Anaerobic infections (e.g., those originating in the pelvis or intestines) Anaerobic
or mixed infections of the CNS
• (6) Rickettsial infections in pregnant patients, tetracycline-allergic patients, and
renally impaired patients
• Oral : 50mg/kg, ear drops: 5% 2-3 drops, eye drops: 0.5% drops
13. 1. Chloramphenicol can cause bone marrow suppression (dose-related) with
resulting pancytopenia; rarely, the drug leads to aplastic anemia (not related to
dose).
2. Hypersensitivity reactions may include skin rash and, in extremely rare
cases, angioedema or anaphylaxis.
3. Chloramphenicol therapy may lead to gray baby syndrome in neonates
(especially premature infants). This dangerous reaction, which stems partly
from inadequate liver detoxification of the drug, is manifested by vomiting,
gray cyanosis, rapid and irregular respirations, vasomotor collapse, and in
some cases death.
14.
15. • Thiamphenicol (also known as thiophenicol and dextrosulphenidol) is
an antibiotic.
• It is the methyl- sulfonyl analogue of chloramphenicol and has a similar spectrum
of activity, but is 2.5 to 5 times as potent.
• Pharmacokinetics
• Absorption: Peak serum concentrations: 2 hr.
Distribution: Diffuses into the CSF, across the placenta, into breast milk and into
the lungs. Protein binding: 10%. Half-life: 2-3 hr, increased in renal impairment.
Metabolism: Undergoes little or no conjugation with glucuronic acid in the liver.
Excretion: Excreted in the urine mainly as unchanged drug (70%); small amount
excreted in bile and faeces.
16. • Interactions: Drugs that depress bone marrow function.
• Indications oral only 1.5gm daily divided dose
• Sexually transmitted diseases; Susceptible infections
• Gonorrhoea
17. • Adverse effects of Chloramphenicol-
BIG Super Hypersensitivity
B- Bone marrow depression
I- Irritative effects like nausea, vomiting, diarrhoea, pain on injection
G- Gray baby syndrome
Super- super infections
Hypersensitivity reactions like rashes, fever, angioedema